Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FNS who wrote (546)	2/3/1998 1:18:00 AM
From: FNS	Read Replies (1) of 965

Misc info on Biogen (BGEN):...primarily #1 MS drug avonex (interferon-beta1) driving stock but others in pipleline including trial candidate for angioplasty. <<The Company expects Merck to begin clinical trials this spring of Biogen's anti-VLA4 inhibitor molecule as a potential treatment for asthma and also anticipates that The Medicines Company will begin trials of Biogen's HIRULOG(R) in angioplasty and acute myocardial infarction.>> BGEN double bottomed around 33 and broke out around 36 and now 42 3/4...old high is 50+. 350- million in cash and no debt! As I recall they made $1.15 for the year '97 vs .55 for '96. Looks like other biotechs are pursuing the angioplasty and myocardial syndrome area.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next